Molecules to Market (MtM) launches new herpes virus rapid test:
This article was originally published in Clinica
Molecules to Market will launch the first rapid, point-of-care test for herpes simplex virus type 2 at the Congress of the European Academy of Dermatology and Venereology in Dublin this month. POCkit HSV 2 Rapid Test can specifically detect HSV 2 antigens in blood, enabling infection to be detected whether lesions are present or not, and gives results in 5-10 minutes. The kit will be marketed by MtM's Diagnology subsidiary.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.